Paricalcitol and Chemotherapy in Treating Women With Metastatic Breast Cancer
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle
formulation, docetaxel,, paclitaxel, and ixabepilone work in different ways to stop the
growth of tumor cells, either by killing the cells or by stopping them from dividing.
Paricalcitol may help chemotherapy drugs to kill more tumor cells by making tumor cells more
sensitive to the drugs.
PURPOSE: This clinical trial is studying the best dose and best way to give paricalcitol and
to see how well it works when given together with chemotherapy in treating patients with
metastatic breast cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Comprehensive Cancer Center of Wake Forest University Wake Forest University Health Sciences